
Amex Q2 results prove it's still the heavyweight of high-end cards
But if the competition is heating up, luxury card stalwart American Express isn't feeling it. The credit card company just beat profit expectations in its second quarter earnings, a feat powered by strong spending that shows Amex cardholders aren't jumping ship for rivals.
With markets unstable and tariffs flying, Amex's laser focus on wealthy customers likely provides a buffer against financial forces that can put a drag on lower income spenders. 'We saw record Card Member spending in the quarter, demand for our premium products was strong,and our credit performance remained best in class,' American Express CEO Stephen Squeri said.
The company's billed business for the quarter was $416.3 billion, besting analyst estimates of $412.8 billion in card member spending. Total revenue was up 9% to $17.9 billion, an increase the credit card issuer attributed to more customer spending, card feed growth and higher income from revolving loan balances.
Fending off the competition
American Express is the old guard among premium rewards cards, but the company knows it needs to keep things fresh to stay competitive. The company recently announced its biggest card refresh to date, with reimagined perks designed to court the Gen Z and millennial cardholders who make up more than a third of its U.S. consumer spending.
'We're going to take these Cards to a new level, not only in what they offer in travel, dining and lifestyle benefits, but also in how they look and feel, to meet the evolving needs of our customers,' American Express Group President of U.S. Consumer Services Howard Grosfield said.
Amex isn't sharing the specifics of its Platinum Card revamp yet, but other changes on the way soon reveal the company's preference for bespoke perks designed to smooth air travel's many jagged edges.
As Fast Company reported, Amex will roll out a pair of luxe updates that exemplify how the company plans to bolster its premium strategy. First, its Centurion Lounges will soon be revamped with rotating menus from James Beard Award-winning chefs, part of its new 'Culinary Collective.' All 15 Centurion Lounges in the U.S. will feature the new menu items starting at the end of the month.
'You'd be lucky to get into each of their restaurants on a normal day,' American Express Travel President Audrey Hendley told Fast Company. 'Now, you can try them all in one trip.'
Amex will also launch Sidecar, a new kind of lounge tailored to the needs of travelers seeking a short-term sanctuary, next year in Las Vegas's Harry Reid International Airport. The lounge will offer small plates and table-side service designed to fit into a limited time slot.
'We're seeing a significant segment of travelers who only spend 30 to 45 minutes in the lounge,' Hendley told Fast Company. 'Sidecar is our way of honoring that time with the same level of care and service.
In the battleground of premium perks, everyone is vying to offer a little something special. Chase recently revamped its famed Sapphire Reserve card with a set of new travel credits and a higher annual fee. Citi is launching its own new premium card, the Citi Strata Elite, later this year to lure affluent customers away from the competition.
If those challengers pose a real threat to Amex, you wouldn't know it. 'Bring it on,' AmEx Chief Financial Officer Christophe Le Caillec told Reuters. 'We've been in that space for decades and we have built assets that our competitors do not have.'
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
8 minutes ago
- Yahoo
Trump tariffs: What are the sticking points in the Canada-US trade negotiation
Prime Minister Mark Carney has remained tight lipped following U.S. President Donald Trump's announcement he would raise the tariff on Canada from 25 per cent to 35 per cent. His policy, while Canada-U.S. trade talks are ongoing, is not to negotiate in public. Mercedes Stephenson breaks down the major sticking points that could be slowing down the negotiations.
Yahoo
8 minutes ago
- Yahoo
OLIVE YOUNG Brings Leading K-Beauty Brands and "All Live Young" Philosophy to KCON LA 2025 as Title Sponsor
LOS ANGELES, Aug. 1, 2025 /PRNewswire/ -- OLIVE YOUNG, South Korea's leading beauty and wellness retailer, returns as the title sponsor of KCON LA 2025, bringing its signature "All Live Young" philosophy to life through a dynamic and immersive K-beauty experience in the heart of Los Angeles. This activation marks a major milestone in the brand's journey to bring its trusted K-beauty experience to North America, with its first U.S. store set to open in Los Angeles in late H1 2026. The brand's presence at KCON reflects its commitment to making K-beauty more accessible, inclusive, and experience-driven for global audiences. At KCON LA, OLIVE YOUNG will spotlight a total of 66 brands including their award-winning private label brands—BIOHEAL BOH, BRINGGREEN, and COLORGRAM— where 164 products from 64 brands will be featured through immersive, interactive zones designed to introduce U.S. audiences to the brand's curated approach to skincare, color, and wellness. Booth Highlights Include:K-Skincare Starter Kit: "Beauty Box" Pop-Up with Global App IntegrationAs part of the pop-up experience, attendees are invited to discover OLIVE YOUNG's "Beauty Box," a curated starter kit featuring standout products from six K-beauty brands available in the U.S. assortment, including Biodance, numbuzin, and ROUND LAB. Guests who engage in the experience will have the opportunity to extend their discovery journey through the OLIVE YOUNG Global website and app, where a limited-time exclusive chance to explore a pop-up offering will be available. Core Skincare Showcase: A Glimpse into the First U.S. StoreA dedicated zone spotlights OLIVE YOUNG's four essential skincare categories—Essence & Serum, Sun Care, Sheet Masks & Pads, and Creams—offering a first look at hero SKUs likely to be included in the upcoming U.S. retail launch.. Exclusive Experience Zones: Discover OLIVE YOUNG's Private BrandsVisitors can immerse themselves in interactive brand zones from OLIVE YOUNG's top-performing private labels: BIOHEAL BOH: Explore anti-aging and lifting solutions in the BIOHEAL BOH Lab. BRINGGREEN: Get personalized skin trouble diagnosis at the BRINGGREEN Nurse's Office. COLORGRAM: Play with high-quality color at COLORGRAM's Colorful Art Room. "We're excited to bring our 'All Live Young' philosophy to life at KCON LA 2025 through curated products, thoughtful retail innovation, and a focus on experience," said Sehoon Jin, Executive Vice President of Global Platform Business at OLIVE YOUNG. "This is a meaningful step in bringing OLIVE YOUNG's trusted and inclusive K-beauty experience to the U.S. market." For more information about OLIVE YOUNG and its private label brands, visit ABOUT OLIVE YOUNG: Established in 1999, OLIVE YOUNG is South Korea's leading beauty and health retailer, dedicated to helping everyone live a healthy and beautiful life. The brand philosophy, "All Live Young," reflects OLIVE YOUNG's vision of inspiring customers to embrace wellness and beauty at every stage of life. Through its flagship store and online platforms, OLIVE YOUNG offers a curated selection of trendy and innovative K-beauty and wellness products, loved by customers worldwide. With over 1,370 stores, more than 20 years of expertise, and strong global partnerships, OLIVE YOUNG continues to set the standard for innovation, accessibility, and customer-focused retail in the K-beauty and wellness industry. As part of CJ Group, a global lifestyle company based in South Korea, OLIVE YOUNG delivers the value of healthy beauty to customers everywhere. MEDIA CONTACT: For more information and interview requests, please contact PURPLE: oliveyoung@ View original content to download multimedia: SOURCE OLIVE YOUNG Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
8 minutes ago
- Yahoo
DEA Accountability as Cannabis Research Crisis Deepens And Patients Suffer
With the confirmation of incoming DEA Administrator Terrance Cole, the opportunity for reform has arrived. The DEA must choose between outdated drug war politics and advancing public health. MMJ International Holdings Issues Clarification on Irvine Labs. WASHINGTON, DC / / August 1, 2025 / MMJ International Holdings, Inc. ("MMJ") today issued a public clarification regarding prior statements about Irvine Labs, Inc., while calling for an urgent reckoning with the U.S. Drug Enforcement Administration's (DEA) catastrophic mismanagement of America's cannabis research policy. In a previous press release, MMJ referenced widespread inactivity among DEA-registered marijuana manufacturers. While these statements were intended to highlight systemic failures within the DEA's quota and licensing system, MMJ acknowledges that this language may have unintentionally caused confusion regarding Irvine Labs, Inc. MMJ hereby clarifies that Irvine Labs, Inc. is a registered DEA entity and, to the best of MMJ's current knowledge, holds valid DEA registrations. MMJ did not intend to imply that Irvine Labs is inactive or insolvent, and any interpretation suggesting otherwise is hereby retracted. This clarification, however, does not alter the underlying crisis: the DEA's marijuana manufacturing quota system is fundamentally broken. Despite a supposed expansion of DEA licenses, no registrant-except MMJ-has produced sufficient pharmaceutical-grade cannabis to support a single FDA-compliant clinical trial. The Devastating Reality: Maridose (Maine): Only 1,100 sq. ft. of space, not growing. Bright Green Corp: Surrendered its registration without ever planting a crop. Royal Emerald Pharmaceuticals: Inactive and facing financial distress. Groff NA Hemplex & Scottsdale Research Institute: No active cultivation for clinical trials. BRC: Producing quantities far below clinical thresholds. University of Mississippi: Continues to grow substandard, research-incompatible marijuana. MMJ remains the only federally compliant entity actively pursuing the cultivation of strain-specific, pharmaceutical-grade cannabis for FDA-approved clinical trials targeting Huntington's Disease and Multiple Sclerosis. Yet, for over seven years, the DEA has obstructed MMJ's efforts through unconstitutional administrative proceedings, arbitrary quotas, and a bureaucratic "Catch-22" that demands documentation (BFSA) which is unattainable without the very registration the DEA refuses to grant. A Constitutional Crisis Exposed The Supreme Court's rulings in Axon v. FTC and Jarkesy v. SEC have now exposed the DEA's internal administrative law judge (ALJ) system as an unconstitutional charade. Despite this, DEA legal counsel Aarathi Haig continues to defend a system the Department of Justice has now abandoned. Former Chief ALJ John "McLooney" Mulrooney has since retired, leaving behind what critics call a "legal dumpster fire." MMJ's legal exceptions, filed July 3, 2025, detail the agency's structural bias, retroactive sabotage, and deliberate obstruction of medical research. "We followed every law, built the FDA-inspected facility, and secured our clinical approvals," said Duane Boise, CEO of MMJ International Holdings. "What the DEA calls regulation is nothing more than bureaucratic revenge." The Time for Reckoning is Now With the confirmation of incoming DEA Administrator Terrance Cole, the opportunity for reform has arrived. The DEA must choose between outdated drug war politics and advancing public health. This demands immediate action: Fire entrenched obstructionists like Thomas Prevoznik. Investigate Aarathi Haig for perpetuating unconstitutional legal processes. Transfer oversight of cannabis research to the FDA, where science-not sabotage-will guide policy. "The DEA has spent a decade fortifying a broken system that protects monopolies, obstructs innovation, and ignores public safety disasters like the Assured Testing Labs scandal in Massachusetts," said Boise. "America doesn't need another anti-marijuana crooner in a suit-it needs a leader who will stand up to this agency's sabotage and put patients first." MMJ International Holdings remains committed to factual accuracy and will continue to expose systemic failures that endanger patients, stifle science, and betray the public trust. MMJ is represented by attorney Megan Sheehan. CONTACT:Madison HiseyMHisey@ SOURCE: MMJ International Holdings View the original press release on ACCESS Newswire Sign in to access your portfolio